Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
La Revue De Medecine Interne
|
January 1, 1994
[CA 15-3 and breast cancer]
E Antoine, L Kayitalire, M Spielmann
Investigational New Drugs
|
November 1, 1992
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer
L Kayitalire, F Thomas, T Le Chevalier, et al.
British Journal of Cancer
|
April 21, 2005
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin
X M Li, K Tanaka, J Sun, et al.
Bulletin Du Cancer
|
October 1, 1994
[Soft tissue sarcomas: general review]
K Fizazi, I Cojean, A Le Cesne, et al.
Bulletin Du Cancer
|
March 6, 1999
[Compassionate use of gemcitabine in advanced pancreatic cancer: a French multicentric study]
J E Kurtz, V Trillet-Lenoir, R Bugat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 14, 2006
Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study
V Westeel, J L Breton, D Braun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas
A Le Cesne, E Antoine, M Spielmann, et al.
Gynecologic Oncology
|
October 8, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study
D Belpomme, I Krakowski, M Beauduin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
M Friedlander, M J Millward, D Bell, et al.
Hepato-Gastroenterology
|
December 2, 2000
Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study
J E Kurtz, F Kohser, S Négrier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
La Revue De Medecine Interne
|
January 1, 1994
[CA 15-3 and breast cancer]
E Antoine, L Kayitalire, M Spielmann
Investigational New Drugs
|
November 1, 1992
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer
L Kayitalire, F Thomas, T Le Chevalier, et al.
British Journal of Cancer
|
April 21, 2005
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin
X M Li, K Tanaka, J Sun, et al.
Bulletin Du Cancer
|
October 1, 1994
[Soft tissue sarcomas: general review]
K Fizazi, I Cojean, A Le Cesne, et al.
Bulletin Du Cancer
|
March 6, 1999
[Compassionate use of gemcitabine in advanced pancreatic cancer: a French multicentric study]
J E Kurtz, V Trillet-Lenoir, R Bugat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 14, 2006
Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study
V Westeel, J L Breton, D Braun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas
A Le Cesne, E Antoine, M Spielmann, et al.
Gynecologic Oncology
|
October 8, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study
D Belpomme, I Krakowski, M Beauduin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
M Friedlander, M J Millward, D Bell, et al.
Hepato-Gastroenterology
|
December 2, 2000
Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study
J E Kurtz, F Kohser, S Négrier, et al.
Page
of 2